{"entities": {"urls": [{"start": 102, "end": 125, "url": "https://t.co/pPfy9T8tM7", "expanded_url": "https://trib.al/JWIOXV9", "display_url": "trib.al/JWIOXV9", "status": 200, "unwound_url": "https://www.bloomberg.com/news/features/2020-04-20/antibody-treatments-may-be-the-best-hope-against-the-virus-until-a-vaccine?utm_medium=social&utm_content=businessweek&utm_campaign=socialflow-organic&cmpid=socialflow-twitter-businessweek&utm_source=twitter"}]}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "author_id": "67358777", "id": "1252209516487335938", "possibly_sensitive": false, "lang": "en", "conversation_id": "1252209516487335938", "created_at": "2020-04-20T12:16:28.000Z", "public_metrics": {"retweet_count": 471, "reply_count": 65, "like_count": 773, "quote_count": 101}, "reply_settings": "everyone", "text": "Regeneron\u2019s coronavirus treatment won\u2019t be cheap, or convenient, but it could be saving lives by fall https://t.co/pPfy9T8tM7", "source": "SocialFlow"}